ABSTRACT: Two hundred forty five market-stressed bull and steer calves (205 ± 14 kg) were received in January and September 2001 to determine the response of acute-phase proteins to dietary energy and starch concentrations and to determine whether acute-phase proteins could be used as a diagnostic or prognostic tool for calves affected by bovine respiratory disease. On arrival, calves were randomly assigned to one of two dietary energy levels (0.85 or 1.07 Mcal of NE g /kg of DM) and one of two dietary starch levels (34 or 48% of dietary ME from starch; n = 5 pens/treatment). All calves were weighed, and plasma and serum samples were collected from a subset of animals (n = 6 calves/ pen; 30 calves/treatment) on d 0, 7, 14, 28, and 42 of the receiving period. This subset of calves (n = 120) was used for all subsequent analyses. Concentrations of fibrinogen (Fb), haptoglobin (Hp), and serum amyloid-A (SaA) were determined. In addition, samples were collected from the subset of calves when they received medical treatment and 7 d following treatment to mea-
Introduction
Although producers continue to use a number of vaccines and antimicrobials to control the major pathogenic contributors to bovine respiratory disease (BRD), it continues to be the most economically significant dis-1 Approved for publication by the Director of the Oklahoma Agric. Exp. Stn. This research was supported under project H-2438.
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sure serum concentrations of Hp and SaA. Serum concentrations of Fb, Hp, and SaA did not differ among dietary treatments, but decreased (P < 0.03) as day of the receiving period increased. Fibrinogen (P < 0.001) and the ratio of Fb:total blood protein were greater (P < 0.003) in calves treated multiple times than in calves never treated or treated once for bovine respiratory disease. In addition, on d 0 and 7, Hp concentration increased (antimicrobial treatment × day interaction, P < 0.03) as the number of antimicrobial treatments increased, and was greater on d 14 and 28 in calves treated multiple times than in calves never treated or treated once. Haptoglobin concentration was greater (P < 0.05) in calves on medical treatment days compared with recovery days (7 d after medical treatment). Although diet seemed to have little effect on acute-phase protein response, these results suggest that haptoglobin may be useful as a diagnostic tool to make management decisions regarding treatment protocols for calves with bovine respiratory disease. ease condition in feedlots (Loneragan et al., 2001) . Diagnosis of BRD in cattle is subjective and is often conducted by personnel with limited training. A diagnostic tool to identify infection would be useful to producers and veterinarians by providing a more objective diagnosis of sick animals. The measurement of acute-phase proteins has potential as a diagnostic and prognostic tool in cattle.
Numerous reports on the use of acute-phase protein responses to predict severity or chronicity of cattle diseases have been published Horadagoda et al., 1999; Carter et al., 2002) . Alsemgeest et al. (1994) indicated that serum haptoglobin (Hp) and serum amyloid-A (SaA) concentrations, as well as Hp:SaA ratios, were elevated in cattle with inflammatory disease, and that serum Hp concentrations and Hp:SaA values were elevated in cases of chronic rather than acute inflammation. In contrast, Horadagoda et al. (1999) found that Hp, SaA, and α-1-acid glycoprotein were greater in cases of acute compared with chronic inflammation. Because those studies examined a large variety of inflammatory diseases, their results may not be comparable to cattle with naturally acquired BRD. The objectives of this experiment were to evaluate serum concentrations of fibrinogen (Fb), Fb:total protein, Hp, and SaA in a large group of feedlot calves receiving various dietary concentrations of energy and starch, and to correlate changes in acute-phase proteins with development of BRD and responses to antimicrobial therapy.
Materials and Methods
All procedures used for this experiment were approved by the Oklahoma State University Animal Care and Use Committee.
Experimental Design
Two hundred forty-five bull and steer calves (initial BW = 205 ± 14 kg) were received at the Willard Sparks Beef Research Center (Stillwater, OK) beginning in January 2001. Two truckloads (n = 167 calves) arrived on January 21, 2001, and an additional truckload (n = 78 calves) arrived on September 15, 2001. Calves were blocked by arrival date into two groups (Groups 2 and 4; Berry et al., 2004) . Calves from Group 2 were commingled and randomly assigned to 12 pens (three replicates/treatment; 13 or 14 calves/pen), whereas calves from Group 4 were randomly assigned to eight pens (two replicates/treatment; 9 or 10 calves/pen). Methods pertaining to the processing protocol, dietary treatments, and health data collection were described by Berry et al. (2004) . Bulls were left intact until after d 42 of the receiving period because of the potential elevation of acute-phase proteins associated with tissue damage as a result of castration. Dietary treatments included two dietary energy (0.85 or 1.07 Mcal of NE g / kg of feed, DM basis) and two dietary starch (34 or 48% of dietary ME from starch) concentrations calculated using NRC standards Berry et al., 2004) .
Before initial processing, a subsample of six calves/ pen (120 calves; 30 calves/dietary treatment) to be used for whole blood collection was selected randomly using a random number table. This subsample of calves was used for all subsequent analyses. One sample for plasma was collected for each animal (10-mL Vacutainer with sodium heparin; Becton Dickinson, Franklin Lakes, NJ), separated within 12 h of collection, and stored overnight at 4°C for Fb analysis the following day. A serum sample (10-mL Vacutainer with no additive) also was collected, allowed to clot at room temperature, stored overnight at 4°C, centrifuged, and stored at −10°C until laboratory analyses could be conducted. Blood samples for acute-phase protein determination were collected on d 0, 7, 14, and 28.
Blood samples also were collected for Hp and SaA determination from a subsample of six calves/pen after these calves had been diagnosed for BRD. Seven days following the initial antimicrobial treatment, calves were evaluated for signs of continuing BRD. If the calf showed no signs of BRD, an additional blood sample was collected for acute-phase protein determination. In the case of animals that remained morbid, blood samples were collected at the time of clinical recovery. Signs of BRD were determined as described by Berry et al. (2003) . Briefly, calves were evaluated by experienced personnel for signs of respiratory and other diseases. Each calf was given a severity score (0 = normal, 1 = mild, 2 = moderate, 3 = severe, or 4 = mortally ill). An animal was designated as morbid and transferred to the processing facility when it was scored as "severe" or when it was scored as "moderate" and exhibited two or more clinical signs of disease including depression, lack of fill compared with pen mates, cough, altered gait, ocular or nasal discharge, or general physical weakness. On entry to the treatment facility, when the rectal temperature of the calf was 40°C or greater, or when the rectal temperature was less than 40°C but the severity score was "severe," the calf was treated with tilmicosin (10 mg/kg injected subcutaneously; Micotil; Elanco, Indianapolis, IN). When a second antimicrobial treatment was necessary, florfenicol was administered (40 mg/ kg injected subcutaneously; Nuflor, Schering Plough Animal Health, Kenilworth, NJ). Ceftiofur HCl was administered (2.2 mg/kg injected subcutaneously; Excenel, Pharmacia-Upjohn, Kalamazoo, MI) when a third treatment was required.
Laboratory Analyses
Fibrinogen. Plasma samples were delivered to the Boren Veterinary Teaching Hospital Clinical Pathology Laboratory on the Stillwater campus of Oklahoma State University for Fb concentration analysis. Samples were vortexed before depositing 100 L of sample plasma into a microhematocrit tube. Serum Fb concentrations were then determined using heat precipitation (60°C for 3 min) and refractometry as described by Duncan et al. (1994) . The concentrations are reported as Fb concentration (mg/100 mL) or as Fb/total blood protein (mg/100 mg). Total blood protein was assayed as described by Duncan et al. (1994) .
Haptoglobin. Serum Hp concentrations were determined using bovine serum haptoglobin radial immunodiffusion kits (code No. P0105-1, Cardiotech Svcs., Inc., Louisville, KY). Procedures used were derived from or validated by Conner et al. (1989) , Makimura and Usui (1990) , and Skinner et al. (1991) . Bovine serum samples (100 L) were treated with an equal amount of 40 mM solution of L-cysteine (24 mg of L-cysteine dissolved in 5 mL of L-cysteine solvent [1 − e]), and both were added to a single mixing well. Two standards were loaded (5 L) into specified wells. Similarly, one treated sample was loaded into each additional well of the plate. The plate was covered and incubated at 37°C for at least 24 h. Following incubation, results were determined by Least squares means within row with different superscripts differ (P < 0.05).
measuring the external diameter of each precipitin ring to the nearest 0.01 mm with a supplied plastic scale. Absence of a precipitin ring indicated an Hp concentration of less than 10 L/mL, which is in the "normal" range of 5.5 to 24.25 for healthy cattle (Saini et al., 1998) . The results were plotted on the vertical axis of a semilogarithmic graph, and Hp concentration (g/ mL) was determined from the horizontal axis. A twofold dilution factor was used to develop the reference curve by plotting the ring diameters against two known dilutions. The coefficient of variation for the kit was less than 4% for repeated, identical measurements on the same specimen.
Serum Amyloid-A. Serum amyloid-A concentrations (ng/mL) were determined using commercial ELISA kits (Tridelta Phase Range kit, Tridelta Development, Ltd., Wicklow, Ireland). Serum samples were vortexed and added (50 L diluted 1:500; one sample per well) to each well of a 12 × 8 microtiter strip coated with a monoclonal antibody specific for SaA along with biotinylated anti-SaA monoclonal antibody (50 L; diluted 1:100 in 1× diluent buffer). Plates were covered and incubated at 37°C for at least 1 h, followed by a complete wash (6×) to remove unbound material. Streptavidinhorseradish peroxidase diluted 1:4,000 (100 L) was added to each well and the plate was incubated at room temperature in darkness for 30 min. The plates were washed again (6×) and tapped dry. Substrate (100 L) was added, and the plates were incubated at room temperature in darkness for an additional 30 min. Stop solution was added, and the plates were read in an automated plate reader (V Max Kinetic Microplate Reader, Molecular Devices, Inc., Sunnyvale, CA) at optical density 490.
Statistical Analyses. Acute-phase protein response to dietary treatment was analyzed using the MIXED procedure of SAS (SAS Inst., Inc., Cary, NC) as a randomized complete block with a 2 × 2 factorial treatment structure. Pen was used as the experimental unit. To minimize sex effects, the subsample of calves was assigned within pens such that each pen had the same number of steers and bulls. Main effects were the two levels of energy and two levels of ME contribution from starch. Repeated measures were taken over days, and the model included fixed effects of energy, starch, days, and the appropriate two-and three-way interactions (Littell et al., 1998) . The proper covariance structure was determined to be autoregressive 1. In addition, analysis was conducted to determine whether differences in acute-phase protein concentrations could be detected in calves that were never treated for BRD, calves that were treated only once for BRD, or calves that required multiple antimicrobial treatments for BRD. For this analysis, individual animal was used as the experimental unit because the number of times treated was recorded for each animal. The model included fixed effects of number of antimicrobial treatments, day of sampling, and the antimicrobial treatments × day interaction. Least squares means were compared using LSD protected by a significant (P < 0.05) F-value. Regression analysis was conducted using the REG procedure of SAS, with number of times treated (0, 1, >1) as the independent variable and acutephase protein concentration as a dependent variable. Results are discussed as significant when P < 0.05 and as a tendencies when P > 0.05 and P < 0.10.
Results and Discussion
Effects of dietary energy and starch on animal performance and health of newly received feedlot calves were previously reported by Berry et al. (2004) . Dietary treatment did not affect morbidity of calves. Of the subset of 120 calves used in the present experiment, 37.5% were never treated, 28.3% received one antimicrobial treatment, 25.0% received two or more antimicrobial treatments, and 9.2% were removed from the experiment due to animal welfare issues (Berry et al., 2004) .
Fibrinogen
There were no dietary energy × starch or dietary energy × starch × day of sampling interactions for Fb concentration (data not shown). In addition, dietary energy or starch levels did not affect Fb concentration. Fibrinogen concentration was greater (P < 0.05) on d 0 and 7 than on d 14, and was greater on d 14 than on d 28 (Table 1) . A similar response was observed when Fb was expressed as a percentage of total blood protein.
Results of Fb concentrations for calves receiving no (Med0), one (Med1), or more than one (Med>1) antimicrobial treatment are shown in Table 2 . Calves receiv- Means in same row with different superscript differ (P < 0.05).
ing Med0 or Med1 had lower (P < 0.05) Fb concentrations and lower Fb:total protein compared with calves receiving Med>1. Although these data suggest that Fb concentration and/or Fb:total protein may be useful in identifying calves that will require multiple antimicrobial treatments, regression analysis showed a lack of fit between the number of antimicrobial treatments and Fb concentration (r 2 = 0.04; P < 0.04) or Fb:total blood protein (r 2 = 0.05; P < 0.03) on d 0. Similar to our results, Carter et al. (2002) found no effect of number of antimicrobial treatments on serum Fb concentrations, and suggested that serum Fb concentrations might not be useful for predicting illness or responses to antimicrobial treatment in cattle with naturally acquired BRD. Duncan et al. (1994) suggested that Fb:total protein concentration might be more accurate at assessing the acute-phase response than Fb concentration alone. Fibrinogen/total protein concentration was not examined in the study of Carter et al. (2002) ; however, response of Fb:total protein to BRD was similar to the response of Fb concentration in the present experiment.
Haptoglobin
Similar to Fb, no dietary energy × starch × day interactions were detected, and dietary energy or starch levels did not affect serum Hp concentration (data not shown). However, serum Hp concentration was greater Standard error of the least squares means = 164.1. There was a med × day interaction (P < 0.03). Means in same row with different superscript differ (P < 0.05).
x,y,z Means in columns within acute-phase protein with different superscripts differ (P < 0.05).
(P < 0.05) on d 7 than on d 0, and Hp concentrations decreased below d-0 concentrations by d 14 (Table 1) .
There was an antimicrobial treatment × sampling day interaction (P < 0.03) for serum Hp concentration (Table 3) Similarly, from serum harvested on d 7, the number of medical treatments required could be predicted as:
Antimicrobial treatments = 0.514 (± 0.120) + 0.0005 (± 0.0001) × [Hp, g/mL] (r 2 = 0.17; P < 0.001). Carter et al. (2002) found that serum Hp concentrations were greater in calves that were treated more than once for BRD than in calves not treated or treated only once, similar to the present results. In addition, significant correlations between Hp concentration and number of treatments were observed on d 0 (r = 0.35) and d 7 (r = 0.20). Serum Hp concentrations have been previously described in sick and healthy cattle. Similar to the present experiment, Godson et al. (1996) found that serum Hp concentrations corresponded to the severity of respiratory disease in calves experimentally inoculated with bovine herpesvirus-1 and Mannheimia haemolytica. Young et al. (1996) measured serum Hp concentrations Table 4 . Concentrations of acute-phase proteins when cattle were diagnosed as morbid and determined to be recovered of calves at three time periods (d 0, 40, and 60) during a feeding trial. These researchers reported that 58% of the calves sampled had detectable serum Hp concentrations in at least one sample. Calves subsequently diagnosed with clinical BRD had a greater (P < 0.05) proportion of calves with elevated Hp concentrations. Wittum et al. (1996) reported that feedlot cattle with clinical BRD that were treated with antimicrobials had lower Hp concentrations than cattle with BRD that were not treated. Table 4 shows the Hp concentration of calves during antimicrobial treatment and 7 d after antimicrobial treatment (i.e., recovery) for the present experiment. Calves fed the low-energy, high-starch diet had lower (P < 0.05) Hp concentrations compared with calves fed the low-energy, low-starch and high-energy, low-starch diets during antimicrobial treatment. All calves treated for BRD had greater (P < 0.05) Hp concentrations when treated compared with recovery concentrations, suggesting serum Hp concentration may serve as a useful diagnostic tool.
Serum Amyloid-A
Serum amyloid-A concentration did not differ among dietary treatments (data not shown), but was lower (P < 0.03) on d 28 than on d 0 or 7. In contrast with Fb and Hp, SaA concentrations were not different (P < 0.63) among Med0, Med1, and Med>1 calves (Table 2) . Serum amyloid-A concentrations also did not differ in serum collected from morbid vs. recovered calves (Table  4 ). Our data suggest that SaA may not be useful as a diagnosis or prognosis tool. Other researchers have questioned the efficacy of SaA as a diagnostic tool because it may be elevated under stressful situations (Alsemgeest, 1995) . Alsemgeest (1995) tested this hypothesis using two stress levels created by housing groups of five cows on different types of floors, videotaping the animals, and assessing stress. Plasma SaA concentrations were elevated in cattle housed on floors associated with the highest levels of physical stress, whereas Hp concentrations were not elevated. In addition, Heegaard et al. (2000) found that the magnitude and duration of serum Hp concentration correlated well with the severity of experimental bovine respiratory syncytial virus infection, whereas serum SaA concentrations increased most rapidly following infection. Carter et al. (2002) tested the value of using SaA, Fb, α 1 − acid glycoprotein, or Hp blood concentrations to predict morbidity in stressed calves and concluded that Hp concentration was the only stand-alone test with any predictive value. Although Hp:SaA ratios showed some promise as a predictive tool, Carter et al. (2002) suggested that the reliability of the predictions derived from Hp was greater than for Hp:SaA. In the present experiment, serum Hp:SaA (P = 0.16) were 2.58, 4.02, and 5.92 for Med0, Med1, and Med>1, respectively.
Implications
Acute-phase protein concentrations generally did not differ among dietary treatments; however, the acutephase proteins varied in response to morbidity in calves. Serum haptoglobin concentration increased as the number of antimicrobial treatments increased and could potentially be used to predict the number of treatments a calf would require. Fibrinogen and Fb:total protein concentrations also were greater in morbid calves, but the relationship between Fb concentration on d 0 and subsequent antimicrobial treatments was low. Our data suggest that haptoglobin concentration may be useful for producers and veterinarians to make health management decisions based on objective evaluations.
